SPOTLIGHT -
Survey: COVID-19 vaccine hesitancy remains high
Top reasons cited to refuse the shots include questions of safety and effectiveness.
Coronavirus: FDA opposes vaccine dose deviations
After an official floated the idea of only giving patients a partial dose of Moderna’s vaccine, the FDA stepped in to clarify.
Report: Primary care physicians still waiting for COVID-19 vaccination
Update: Physician organizations are speaking out against the issue.
Coronavirus: Moderna on pace to produce even more vaccine than planned
The drug maker revised its lower estimate for global production by 100 million doses.
Coronavirus: FDA grants Moderna vaccine EUA
Moderna‘s vaccine showed 94.1 percent efficacy in patients 16 and older.
Coronavirus: Moderna vaccine clears EUA hurdle
A regulatory panel has given the vaccine approval leaving only the official EUA approval before distribution.
Coronavirus: Organizations urge healthcare workers to get vaccinated
The organizations also thanks healthcare professionals for their work throughout the pandemic.
Coronavirus: Majority of public say they’re likely to get vaccinated
A survey has found an increase in the share of the general public willing to receive a COVID-19 vaccine.
Coronavirus: ACP backs vaccine recommendations
The organization supports recommendations for the Pfizer BioNTech vaccine.
Coronavirus: Moderna vaccine nears EUA
The vaccine is expected to be authorized for emergency use later this week.
Coronavirus: FDA grants Pfizer vaccine EUA
The authorization came late Friday night.
Coronavirus: Pfizer vaccine nears EUA
The Vaccines and Related Biological Products Advisory Committee approved the vaccine, BNT162b2, paving the way to emergency use authorization.
Coronavirus: FDA report looks good for Pfizer vaccine EUA
The report came out as the U.K. has started vaccinating patients.
ACP urges influenza vaccination
As National Influenza Vaccination Week approaches, it’s time for all adults to get a flu shot.
Coronavirus: UK approves Pfizer vaccine candidate
The UK leapfrogged the rest of the western world in accepting the candidate which is shown to be about 95 percent effective against COVID-19.
Coronavirus: ACP supports ethical distribution of COVID-19 and other vaccines
The organization is recommending a framework to ensure ethical allocations of much-needed vaccines during the pandemic.
Coronavirus: Moderna to seek EUA for vaccine candidate
The candidate showed 94.1 percent efficacy against COVID-19 and 100 percent against severe COVID-19.
Coronavirus: Astrazeneca/Oxford vaccine candidate looks promising, company data shows
The company tested two different dosing regimens with one shown to be more effective.
Coronavirus: Pfizer submits vaccine candidate EUA application
The candidate BNT162b2 was shown to be 95 percent effective against COVID-19.
Coronavirus: Final trial shows high efficacy for Pfizer vaccine candidate
BNT162b2 showed 95 percent efficacy against COVID-19.
Moderna coronavirus vaccine candidate shows promise
The latest vaccine candidate showed about 95 percent efficacy in a Phase 3 trial.
Coronavirus: AMA releases vaccine CPT codes
These new codes ensure physicians get paid for keeping their patients safe from COVID-19.
Pfizer coronavirus vaccine candidate shows high efficacy
The candidate was shown to be more than 90 percent effective in preventing COVID-19 infection.
Coronavirus: ACP presses preventive measures
With infections on the rise at the start of flu season, the need for measures to limit transmission is as strong as ever.
Coronavirus: CMS releases plan for vaccine patient price, reimbursement
The interim final rule with comment period would make the vaccine free to patients on Medicare and on most private health plans.
Coronavirus: Worry looms over vaccines
Concerns over efficacy and politics clouds hope for a vaccine to end the COVID-19 pandemic.
Coronavirus: Pfizer CEO says company to seek EUA for vaccine after election
In an open letter, CEO Albert Bouria sought to give clarity to the drug’s development timeline.
Coronavirus: AstraZeneca/Oxford resumes vaccine trial
The trial had been halted due to a side-effect in an English patient.
Coronavirus: Drug executives pledge to ensure vaccine is safe
The pledge seeks to assuage fears that the Trump administration will rush a vaccine into production for political purposes.
Report: CDC urges governors to be ready for coronavirus vaccine by November
In a letter, the agency pushes states to fast-track permitting and licensing for possible distribution sites.